Quantcast

BioInformatics, LLC Studies Effective Strategies for Scientific Publishing in a Web 2.0 World

December 1, 2008

ARLINGTON, Va., Dec. 1 /PRNewswire/ — BioInformatics, LLC
(http://www.gene2drug.com) — the leading market research and consulting firm
serving the life science industry — announces the publication of its latest
report, “The Brave New World of Scientific Publishing.” Going beyond the
original social media study published jointly in 2007 by BioInformatics and
PJA — an award-winning business-to-business advertising and marketing agency
– this report explores the impact of Web 2.0 and Social Media applications on
traditional publishing methodologies, and provides insight on how to best
embrace this new industry standard to maintain a leadership role within the
scientific community.

An in-depth analysis of the opinions of over 1,500 life scientists, this
report uncovers key findings about how scientists rely on the Web for
research, collaboration and networking. Discussion boards, blogs, wikis video
and podcasts — scientists are learning how to employ Web 2.0 and social media
tools to good effect. Additionally, the report indicates that reliance on
traditional media as an information source is waning, while online
collaborative tools are becoming increasingly valuable to today’s researcher.

A North American Lab Director had this to say: “The traditional peer
review system is too slow, outdated, becoming obsolete… articles should be
published right away on the net, linked by aggregator sites so other
scientists can review and post comments online. This would open peer review
to a much wider audience (hundreds can comment instead of 3-4) and should
improve the quality of science.”

Findings reveal that traditional publishing models, while still viable, no
longer stand alone as a way to thrive in a community of scientists who want
more speed, more control and easier access to information than ever before.
Plus, scientists want to be heard. Publishers that understand this — and
adapt — are already taking the lead.

“Our assessment is that publishers are well-placed to deliver social tools
in a secure and trusted environment, but they also need to innovate tools that
are more relevant, focused and easy to use,” observes noted science writer

Richard Grant, who served as a lead consultant on the report.

The time for “wait and see” is past; The Brave New World of Scientific
Publishing provides the advantage required to anticipate and deliver on the
needs of the modern scientist. “An organization must leverage its existing
reputation to join — and influence — the online dialogue,” notes Dr. Tamara
Zemlo
, Director of Syndicated Research and Analysis for BioInformatics, LLC.
This report is a must-read for any company looking to remain competitive
within the rapidly evolving scientific community.

The Brave New World of Scientific Publishing is based on 1,557 responses
to a 37 question online survey fielded to The Science Advisory Board in May
2008
. BioInformatics LLC sponsors this global online community of more than
40,000 scientists, physicians and healthcare professionals.

ABOUT BIOINFORMATICS, LLC

BioInformatics, LLC is the premier research and advisory firm serving the
life science industry. By leveraging our professional social network of more
than 40,000 biomedical researchers, we have supported more than 300 companies
and provided insights that lead to better business decisions. Our assignments
include assessing the size and attractiveness of markets, optimizing product
configurations and pricing, validating corporate acquisitions, measuring
customer loyalty, and evaluating brand strength and positioning.

    To purchase this report or for additional information, please contact:

    Mary Follin
    Director of Communications
    BioInformatics, LLC
    2111 Wilson Blvd., Suite 250
    Arlington, VA  22201
    703.778.3080 x13 (phone)
    m.follin@gene2drug.com

http://www.gene2drug.com/

SOURCE BioInformatics, LLC


Source: newswire



comments powered by Disqus